Quote:
Originally Posted by soccertese
hey, where can i get some of that placebo and how much does it cost? 
The primary endpoint of the study was the change at Week 12 in Unified Parkinson’s Disease Rating Scale-Part 3 (UPDRS III) score relative to placebo at 30 minutes post-treatment for the 84 mg dose. UPDRS III change for the 84 mg dose was -9.83 compared to -5.91 for placebo (p=0.009).
i'm sure this will be a valuable adjunct to l-dopa, wish they had released more data. and tested it against oral C/L just too much time on my hands this morning.
. |
This was just a report of topline results. Full results will be reporte d after all of the analyses are completed by the data management team.
They already have tested this against oral C/L and it was significantly quicker.
Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson's disease. - PubMed - NCBI
https://clinicaltrials.gov/ct2/show/...cvt-301&rank=5